Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
Author(s) -
Wolfgang Kruis,
Britta Siegmund,
Konrad Leśniakowski,
В. И. Симаненков,
Л. В. Хіміон,
Marcin Soboń,
Glebs Delmans,
Svetlana V Maksyashina,
О. А. Саблин,
Juris Pokrotnieks,
Yuriy Mostovoy,
Olena Datsenko,
Sayar Abdulkhakov,
A. E. Dorofeyev,
Olena Levchenko,
Olga Alexeeva,
П. С. Андреев,
Ivan P Kolesnik,
Emese Mihály,
О. Аbrahamovych,
Malgorzata Baluta,
N. M. Kharchenko,
Neshta Viacheslav,
Yury P. Uspenskiy,
Michael Vieth,
Ralf Mohrbacher,
Ralph Müeller,
Roland Greinwald
Publication year - 2022
Publication title -
journal of crohn s and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjac081
Subject(s) - suppository , budesonide , medicine , ulcerative colitis , proctitis , gastroenterology , clinical endpoint , clinical trial , rectum , placebo , randomized controlled trial , surgery , corticosteroid , pharmacology , disease , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom